SlideShare a Scribd company logo
+
DIABETES MELLITUS – AN
EPIDEMIOLOGICAL OVERVIEW
- DR. SOMAK MAJUMDAR
M.D,
DEPTT. OF CFM, AIIMS PATNA
+
INTRODUCTION
Definition - It is a heterogeneous group of
disorders characterized by hyperglycemia,
and disturbances of carbohydrate, fat and
protein metabolism with absolute or relative
deficiency of insulin action and or secretion
a number of complications - cardiovascular,
renal, neurological, ocular and others such
as intercurrent infections.
+
+
INSULIN PRODUCTION AND ACTION
+
TYPE 1 DIABETES
 Aka Insulin-dependent diabetes mellitus
 most severe form of the disease.
 onset is typically abrupt
 usually seen in individuals less than 30 years of age
 immune-mediated in over 90 per cent of cases and idiopathic in less than
10 per cent cases.
 associated with ketosis in its untreated state.
 occurs mostly in children, the incidence is highest among 10-14 year old
group, but occasionally occur in adults.
 catabolic disorder in which circulating insulin is virtually absent, plasma
glucagon is elevated, and the pancreatic cells fail to respond to all
insulinogenic stimuli.
 Exogenous insulin is therefore required to reverse the catabolic state,
prevent ketosis, reduce the hyperglucagonaemia, and reduce blood glucose
+
TYPE 2 DIABETES
 much more common than type 1.
 often discovered by chance.
 gradual in onset
 occurs mainly in the middle-aged and elderly,
 frequently mild, slow to ketosis
 compatible with long survival if given adequate
treatment.
 clinical picture is usually complicated by the presence
of other disease processes.
+
+ THE WHO RECOMMENDATIONS FOR THE DIAGNOSTIC
CRITERIA FOR DIABETES AND INTERMEDIATE
HYPERGLYCAEMIA
+ SYNDROME X
+ CUT-OFFS FOR SYNDROME X
+
+
+
EPIDEMIOLOGY
+
+
+
+
TOP 10 COUNTRIES BY PREVALENCE %
OF DIABETES
+
+
DIABETES IN INDIA
 The population in India has an increased susceptibility to diabetes
mellitus.
 The rates of diabetes in migrants from the Indian subcontinent have
consistently shown to exceed those of the local population
 Current estimates indicate that 8.2% of the adult population, or 72.1
million people, have diabetes, 65.1 million of whom live in India.
 Prevalence of diabetes in India-9.1%
 India accounts for the majority of the children with type 1 diabetes.
+
NATURAL HISTORY - AGENT
 The underlying cause of diabetes is insulin deficiency which is
absolute in type 1 diabetes and partial in type 2 diabetes. This
may be due to a wide variety of mechanisms:
1. pancreatic disorders - inflammatory, neoplastic and other
disorders such as cystic fibrosis,
2. defects in the formation of insulin, e.g., synthesis of an abnormal,
biologically less active insulin molecule;
3. destruction of beta cells, e.g., viral infections and chemical
agents,
4. decreased insulin sensitivity, due to decreased numbers of
adipocyte and monocyte insulin receptors.
5. genetic defects, e.g., mutation of insulin gene; and
6. autoimmunity.
+ NATURAL HISTORY - HOST
AGE • May occur at any age.
• prevalence rises steeply with age.
• Malnutrition related diabetes - young people.
• prognosis is worse in younger diabetics, earlier complications
SEX • Some countries (UK) – male = female
• South-east Asia – male > female
GENETICS • Type 1 diabetes = 50% concordance, not totally genetic but
associated with HLA- DR3, DR4, B8, B15
• Type 2 diabetes = 90% concordance, genetically strong but not
HLA associated.
IMMUNITY Evidence of both cell mediated and humoral immunity
OBESITY Central obesity, duration and degree of obesity, waist circumference,
waist-to-hip ratio, insulin resistance.
MATERNAL
DIABETES
• develop obesity in childhood,
• at high risk of developing type 2 diabetes at an early age.
• Increased risk of subsequent diabetes in the child
+ NATURAL HISTORY - ENVIRONMENT
SEDENTARY LIFESTYLE – lack of exercise leads
to altered interaction between insulin and its
receptors.
HIGHER SATURATED FAT INTAKE – higher
insulin resistance, lower insulin sensitivity, higher
fasting insulin levels.
DIETARY FIBRES – minimum intake of 20 gm/day,
reduced glucose and insulin levels.
MALNUTRITION – partial failure of β cell function,
ALCOHOL – damages pancreas and liver,
promotes obesity.
+ NATURAL HISTORY - ENVIRONMENT
VIRAL INFECTIONS - rubella, mumps, and
human coxsackie virus B4, destroy βcells.
CHEMICALS - alloxan, streptozotocin,
VALCOR, cyanide producing foods (e.g.,
cassava and certain beans) toxic to β cells.
STRESS - Surgery, trauma, and stress of
situations, internal or external, may "bring
out” the disease.
OTHER FACTORS - occupation, marital
status, religion, economic status, education,
urbanization and changes in life style which
common in the lower social classes
+
SCREENING OF DIABETES
URINE EXAMINATION –
commonly used but yields many
false negatives, PPV – 10-50%,
sensitivity  but specificity 
(90%), not useful for
epidemiological surveys.
BLOOD SUGARTESTING –
considered more appropriate, used
for epidemiological surveys,
random, fasting and PP sugar
done, PP sugar after 75g oral
glucose considered best either
alone or with fasting sugar.
RIGHT POPULATION FOR SCREENING
“HIGH RISK GROUPS”
1. those in the age group 40 and over
2. those with a family history of diabetes
3. the obese
4. women who have had a baby weighing more than 4.5
kg (or 3.5 kg in constitutionally small populations)
5. women who show excess weight gain during
pregnancy, and
6. patients with premature atherosclerosis.
PREVENTION OF DIABETES
PRIMARY PREVENTION
POPULATION STRATEGY –
• Primordial prevention
• Maintenance of normal body
weight through adoption of
healthy nutritional habits and
physical exercise.
• An adequate protein intake,
• A high intake of dietary fibre and
avoidance of sweet foods.
• Elimination of other less well
defined factors such as protein
deficiency and food toxins.
• education of patients and their
families to optimize the
effectiveness of primary health
care services.
HIGH-RISK STRATEGY –
• no special high-risk strategy for
type 1 diabetes.
• Genetic counselling may be done
but not feasible at present.
• Correction of sedentary lifestyle,
over-nutrition and obesity for
NIDDM.
• Avoidance of Alcohol, diabetogenic
drugs like oral contraceptives.
• Reduction of factors that promote
atherosclerosis, e.g., smoking, high
blood pressure, elevated
cholesterol and high triglyceride
levels.
• May be directed at target
population groups.
SECONDARY PREVENTION
EARLY DIAGNOSIS –
a) Proper screening
b) Routine checking of blood sugar, of urine for proteins and
ketones, of blood pressure, visual acuity and weight
should be done periodically.
c) The feet should be examined for any defective blood
circulation (Doppler ultrasound probes are advised), loss
of sensation and the health of the skin.
d) Primary health care – of utmost importance.
SECONDARY PREVENTION (cont.)
MANAGEMENT –
• Proper management of the diabetes is most
important to prevent complications.
• Investigations used for early diagnosis should be
done.
• Treatment is based on (a) diet alone - small balanced
meals more frequently, (b) diet and oral anti diabetic
drugs, or (c) diet and insulin.
SECONDARY PREVENTION (cont.)
Glycosylated haemoglobin :
• estimation at 6 monthly intervals.
• long-term index of glucose control.
• rationale: glucose in the blood is complexed to a
certain fraction of haemoglobin to an extent
proportional to the blood glucose concentration.The
percentage of such glycosylated haemoglobin reflects
the mean blood glucose levels during the red cell life-
time (i.e., about the previous 2-3 months)
SECONDARY PREVENTION (cont.)
Home blood glucose monitoring :
• Glucometers - immediate, reasonably accurate, capillary blood glucose
measurements
• the direct reading Haemoglukotest strips .
Self-care :
• adherence to diet and drug regimens,
• examination of his own urine
• blood glucose monitoring
• self administration of insulin,
• abstinence from alcohol,
• maintenance of optimum weight,
• attending periodic check-ups,
• recognition of symptoms associated with glycosuria and hypoglycaemia, etc.
TERTIARY PREVENTION
• Diabetes is major cause of disability through its complications, e.g.,
blindness, kidney failure, coronary thrombosis, gangrene of the lower
extremities, etc.
• The main objective at the tertiary level is to organize specialized clinics
(Diabetic clinics) and units capable of providing diagnostic and
management skills of a high order.
• The tertiary level should also be involved in basic, clinical and
epidemiological research.
• local and national registries for diabetics should be established.

More Related Content

What's hot

Diabetes Self Management
Diabetes Self ManagementDiabetes Self Management
Diabetes Self Management
megbostwick
 
Prevention of type 2 diabetes
Prevention of type 2 diabetesPrevention of type 2 diabetes
Prevention of type 2 diabetes
Mohamed BADR
 
Diabetes
Diabetes Diabetes
Diabetes
Balaji Thorat
 
Epidemiology of diabetes mellitus
Epidemiology of diabetes mellitusEpidemiology of diabetes mellitus
Epidemiology of diabetes mellitus
mgmcricommunitymed
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Sara Ravi
 
Diabetis ppt
Diabetis pptDiabetis ppt
Diabetis ppt
Asraful Islam Rayhan
 
DIABETES MELLITUS by dr aftab ahmed
DIABETES  MELLITUS by dr aftab ahmedDIABETES  MELLITUS by dr aftab ahmed
DIABETES MELLITUS by dr aftab ahmed
aaiman46
 
Link between diabetes and Heart disease
Link between diabetes and Heart diseaseLink between diabetes and Heart disease
Link between diabetes and Heart disease
Saurabh
 
Diabetes (2)
Diabetes (2)Diabetes (2)
Diabetes (2)
lailamemon
 
Type 2 diabetes pathogenesis
Type 2 diabetes pathogenesisType 2 diabetes pathogenesis
Type 2 diabetes pathogenesis
ali Hakimzadeh
 
Epidemiology prevention control of hypertension
Epidemiology prevention control of hypertensionEpidemiology prevention control of hypertension
Epidemiology prevention control of hypertension
Abhi Manu
 
Diabetes case-study
Diabetes case-studyDiabetes case-study
Diabetes case-study
Rozelle Mae Birador
 
Diabetes types and treatment
Diabetes types and treatmentDiabetes types and treatment
Diabetes types and treatment
Kartikey Singh
 
Diabetes management
Diabetes managementDiabetes management
Diabetes management
Akanksha William
 
NCD Program in Malaysia, overview
NCD Program in Malaysia, overviewNCD Program in Malaysia, overview
NCD Program in Malaysia, overview
Feisul Mustapha
 
Prediabetes Awadhesh Med
Prediabetes Awadhesh MedPrediabetes Awadhesh Med
Diabetes powerpoint
Diabetes powerpointDiabetes powerpoint
Diabetes powerpointmldanforth
 

What's hot (20)

Diabetes Self Management
Diabetes Self ManagementDiabetes Self Management
Diabetes Self Management
 
Diabetes Prevention
Diabetes PreventionDiabetes Prevention
Diabetes Prevention
 
Diabetes
DiabetesDiabetes
Diabetes
 
Prevention of type 2 diabetes
Prevention of type 2 diabetesPrevention of type 2 diabetes
Prevention of type 2 diabetes
 
Diabetes
Diabetes Diabetes
Diabetes
 
Epidemiology of diabetes mellitus
Epidemiology of diabetes mellitusEpidemiology of diabetes mellitus
Epidemiology of diabetes mellitus
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetis ppt
Diabetis pptDiabetis ppt
Diabetis ppt
 
DIABETES MELLITUS by dr aftab ahmed
DIABETES  MELLITUS by dr aftab ahmedDIABETES  MELLITUS by dr aftab ahmed
DIABETES MELLITUS by dr aftab ahmed
 
Link between diabetes and Heart disease
Link between diabetes and Heart diseaseLink between diabetes and Heart disease
Link between diabetes and Heart disease
 
Diabetes (2)
Diabetes (2)Diabetes (2)
Diabetes (2)
 
Type 2 diabetes pathogenesis
Type 2 diabetes pathogenesisType 2 diabetes pathogenesis
Type 2 diabetes pathogenesis
 
Epidemiology prevention control of hypertension
Epidemiology prevention control of hypertensionEpidemiology prevention control of hypertension
Epidemiology prevention control of hypertension
 
Diabetes case-study
Diabetes case-studyDiabetes case-study
Diabetes case-study
 
Diabetes types and treatment
Diabetes types and treatmentDiabetes types and treatment
Diabetes types and treatment
 
Diabetes management
Diabetes managementDiabetes management
Diabetes management
 
NCD Program in Malaysia, overview
NCD Program in Malaysia, overviewNCD Program in Malaysia, overview
NCD Program in Malaysia, overview
 
Prediabetes Awadhesh Med
Prediabetes Awadhesh MedPrediabetes Awadhesh Med
Prediabetes Awadhesh Med
 
Diabetes powerpoint
Diabetes powerpointDiabetes powerpoint
Diabetes powerpoint
 

Similar to Diabetes

EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptxEPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
DrHarimuBargayary
 
diabetes mallitus ppt.pptx
diabetes mallitus ppt.pptxdiabetes mallitus ppt.pptx
diabetes mallitus ppt.pptx
Swati Yadav
 
#Diabetes mellitus disease ppt presentation
#Diabetes mellitus disease ppt presentation#Diabetes mellitus disease ppt presentation
#Diabetes mellitus disease ppt presentation
rk17602629
 
Diabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKADiabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKA
Stephen ram
 
Diabetes mellitus (dm) And DKA
Diabetes mellitus (dm) And DKADiabetes mellitus (dm) And DKA
Diabetes mellitus (dm) And DKA
Stephen ram
 
DIABETES MELLITUS -DR Nagaraj kotli sir.pptx
DIABETES MELLITUS -DR Nagaraj kotli sir.pptxDIABETES MELLITUS -DR Nagaraj kotli sir.pptx
DIABETES MELLITUS -DR Nagaraj kotli sir.pptx
NRKAOFFICIAL
 
Diabetus mellitus (seminor)
Diabetus mellitus (seminor) Diabetus mellitus (seminor)
Diabetus mellitus (seminor)
ROMAN BAJRANG
 
Lecture 15(Diabetes Mellitus).pptx
Lecture 15(Diabetes Mellitus).pptxLecture 15(Diabetes Mellitus).pptx
Lecture 15(Diabetes Mellitus).pptx
Lawrence301995
 
Diabetes
Diabetes Diabetes
Diabetes
Hannan Ali Nawaz
 
DM & HTN diabetes mellitus and hypertension.pptx
DM & HTN diabetes mellitus and hypertension.pptxDM & HTN diabetes mellitus and hypertension.pptx
DM & HTN diabetes mellitus and hypertension.pptx
AkilanN5
 
Diabetes mellitus ppt
Diabetes  mellitus pptDiabetes  mellitus ppt
Diabetes mellitus ppt
ROMAN BAJRANG
 
Diabetes Mellitus PPT
Diabetes Mellitus PPTDiabetes Mellitus PPT
Diabetes Mellitus PPT
Divyesh Parmar
 
Diabetes mellitus with complication
Diabetes mellitus with complicationDiabetes mellitus with complication
Diabetes mellitus with complication
Dipali Dumbre
 
Care Conference Diabetes
Care Conference DiabetesCare Conference Diabetes
Care Conference Diabetes
Cikbungazafieya Zawani
 
diabetes mellitus presentation
diabetes mellitus presentationdiabetes mellitus presentation
diabetes mellitus presentation
NighatKanwal
 
Comm Med.pptx
Comm Med.pptxComm Med.pptx
Comm Med.pptx
technew5
 
Dm slides syanthika
Dm slides syanthikaDm slides syanthika
Dm slides syanthika
SYANTHIKADUTTA
 
Diabetes mellitus type 2
Diabetes mellitus type 2Diabetes mellitus type 2
Diabetes mellitus type 2
Esther Mary Mathew
 

Similar to Diabetes (20)

EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptxEPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
EPIDEMIOLOGY AND RECENT ADVANCES IN DIABETES & OBESITY - HARIMU.pptx
 
diabetes mallitus ppt.pptx
diabetes mallitus ppt.pptxdiabetes mallitus ppt.pptx
diabetes mallitus ppt.pptx
 
#Diabetes mellitus disease ppt presentation
#Diabetes mellitus disease ppt presentation#Diabetes mellitus disease ppt presentation
#Diabetes mellitus disease ppt presentation
 
Diabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKADiabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKA
 
Diabetes mellitus (dm) And DKA
Diabetes mellitus (dm) And DKADiabetes mellitus (dm) And DKA
Diabetes mellitus (dm) And DKA
 
DIABETES MELLITUS -DR Nagaraj kotli sir.pptx
DIABETES MELLITUS -DR Nagaraj kotli sir.pptxDIABETES MELLITUS -DR Nagaraj kotli sir.pptx
DIABETES MELLITUS -DR Nagaraj kotli sir.pptx
 
Diabetus mellitus (seminor)
Diabetus mellitus (seminor) Diabetus mellitus (seminor)
Diabetus mellitus (seminor)
 
Lecture 15(Diabetes Mellitus).pptx
Lecture 15(Diabetes Mellitus).pptxLecture 15(Diabetes Mellitus).pptx
Lecture 15(Diabetes Mellitus).pptx
 
Diabetes
Diabetes Diabetes
Diabetes
 
DM & HTN diabetes mellitus and hypertension.pptx
DM & HTN diabetes mellitus and hypertension.pptxDM & HTN diabetes mellitus and hypertension.pptx
DM & HTN diabetes mellitus and hypertension.pptx
 
Diabetes mellitus ppt
Diabetes  mellitus pptDiabetes  mellitus ppt
Diabetes mellitus ppt
 
Diabetes Mellitus PPT
Diabetes Mellitus PPTDiabetes Mellitus PPT
Diabetes Mellitus PPT
 
Diabetes mellitus with complication
Diabetes mellitus with complicationDiabetes mellitus with complication
Diabetes mellitus with complication
 
Care Conference Diabetes
Care Conference DiabetesCare Conference Diabetes
Care Conference Diabetes
 
diabetes mellitus presentation
diabetes mellitus presentationdiabetes mellitus presentation
diabetes mellitus presentation
 
Comm Med.pptx
Comm Med.pptxComm Med.pptx
Comm Med.pptx
 
DM PPT.pptx
DM PPT.pptxDM PPT.pptx
DM PPT.pptx
 
Dm slides syanthika
Dm slides syanthikaDm slides syanthika
Dm slides syanthika
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetes mellitus type 2
Diabetes mellitus type 2Diabetes mellitus type 2
Diabetes mellitus type 2
 

Recently uploaded

THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 

Recently uploaded (20)

THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 

Diabetes

  • 1. + DIABETES MELLITUS – AN EPIDEMIOLOGICAL OVERVIEW - DR. SOMAK MAJUMDAR M.D, DEPTT. OF CFM, AIIMS PATNA
  • 2. + INTRODUCTION Definition - It is a heterogeneous group of disorders characterized by hyperglycemia, and disturbances of carbohydrate, fat and protein metabolism with absolute or relative deficiency of insulin action and or secretion a number of complications - cardiovascular, renal, neurological, ocular and others such as intercurrent infections.
  • 3. +
  • 5. + TYPE 1 DIABETES  Aka Insulin-dependent diabetes mellitus  most severe form of the disease.  onset is typically abrupt  usually seen in individuals less than 30 years of age  immune-mediated in over 90 per cent of cases and idiopathic in less than 10 per cent cases.  associated with ketosis in its untreated state.  occurs mostly in children, the incidence is highest among 10-14 year old group, but occasionally occur in adults.  catabolic disorder in which circulating insulin is virtually absent, plasma glucagon is elevated, and the pancreatic cells fail to respond to all insulinogenic stimuli.  Exogenous insulin is therefore required to reverse the catabolic state, prevent ketosis, reduce the hyperglucagonaemia, and reduce blood glucose
  • 6. + TYPE 2 DIABETES  much more common than type 1.  often discovered by chance.  gradual in onset  occurs mainly in the middle-aged and elderly,  frequently mild, slow to ketosis  compatible with long survival if given adequate treatment.  clinical picture is usually complicated by the presence of other disease processes.
  • 7. +
  • 8. + THE WHO RECOMMENDATIONS FOR THE DIAGNOSTIC CRITERIA FOR DIABETES AND INTERMEDIATE HYPERGLYCAEMIA
  • 10. + CUT-OFFS FOR SYNDROME X
  • 11. +
  • 12. +
  • 14. +
  • 15. +
  • 16. +
  • 17. + TOP 10 COUNTRIES BY PREVALENCE % OF DIABETES
  • 18. +
  • 19. + DIABETES IN INDIA  The population in India has an increased susceptibility to diabetes mellitus.  The rates of diabetes in migrants from the Indian subcontinent have consistently shown to exceed those of the local population  Current estimates indicate that 8.2% of the adult population, or 72.1 million people, have diabetes, 65.1 million of whom live in India.  Prevalence of diabetes in India-9.1%  India accounts for the majority of the children with type 1 diabetes.
  • 20. + NATURAL HISTORY - AGENT  The underlying cause of diabetes is insulin deficiency which is absolute in type 1 diabetes and partial in type 2 diabetes. This may be due to a wide variety of mechanisms: 1. pancreatic disorders - inflammatory, neoplastic and other disorders such as cystic fibrosis, 2. defects in the formation of insulin, e.g., synthesis of an abnormal, biologically less active insulin molecule; 3. destruction of beta cells, e.g., viral infections and chemical agents, 4. decreased insulin sensitivity, due to decreased numbers of adipocyte and monocyte insulin receptors. 5. genetic defects, e.g., mutation of insulin gene; and 6. autoimmunity.
  • 21. + NATURAL HISTORY - HOST AGE • May occur at any age. • prevalence rises steeply with age. • Malnutrition related diabetes - young people. • prognosis is worse in younger diabetics, earlier complications SEX • Some countries (UK) – male = female • South-east Asia – male > female GENETICS • Type 1 diabetes = 50% concordance, not totally genetic but associated with HLA- DR3, DR4, B8, B15 • Type 2 diabetes = 90% concordance, genetically strong but not HLA associated. IMMUNITY Evidence of both cell mediated and humoral immunity OBESITY Central obesity, duration and degree of obesity, waist circumference, waist-to-hip ratio, insulin resistance. MATERNAL DIABETES • develop obesity in childhood, • at high risk of developing type 2 diabetes at an early age. • Increased risk of subsequent diabetes in the child
  • 22. + NATURAL HISTORY - ENVIRONMENT SEDENTARY LIFESTYLE – lack of exercise leads to altered interaction between insulin and its receptors. HIGHER SATURATED FAT INTAKE – higher insulin resistance, lower insulin sensitivity, higher fasting insulin levels. DIETARY FIBRES – minimum intake of 20 gm/day, reduced glucose and insulin levels. MALNUTRITION – partial failure of β cell function, ALCOHOL – damages pancreas and liver, promotes obesity.
  • 23. + NATURAL HISTORY - ENVIRONMENT VIRAL INFECTIONS - rubella, mumps, and human coxsackie virus B4, destroy βcells. CHEMICALS - alloxan, streptozotocin, VALCOR, cyanide producing foods (e.g., cassava and certain beans) toxic to β cells. STRESS - Surgery, trauma, and stress of situations, internal or external, may "bring out” the disease. OTHER FACTORS - occupation, marital status, religion, economic status, education, urbanization and changes in life style which common in the lower social classes
  • 24. +
  • 26. URINE EXAMINATION – commonly used but yields many false negatives, PPV – 10-50%, sensitivity  but specificity  (90%), not useful for epidemiological surveys. BLOOD SUGARTESTING – considered more appropriate, used for epidemiological surveys, random, fasting and PP sugar done, PP sugar after 75g oral glucose considered best either alone or with fasting sugar.
  • 27. RIGHT POPULATION FOR SCREENING “HIGH RISK GROUPS” 1. those in the age group 40 and over 2. those with a family history of diabetes 3. the obese 4. women who have had a baby weighing more than 4.5 kg (or 3.5 kg in constitutionally small populations) 5. women who show excess weight gain during pregnancy, and 6. patients with premature atherosclerosis.
  • 29. PRIMARY PREVENTION POPULATION STRATEGY – • Primordial prevention • Maintenance of normal body weight through adoption of healthy nutritional habits and physical exercise. • An adequate protein intake, • A high intake of dietary fibre and avoidance of sweet foods. • Elimination of other less well defined factors such as protein deficiency and food toxins. • education of patients and their families to optimize the effectiveness of primary health care services. HIGH-RISK STRATEGY – • no special high-risk strategy for type 1 diabetes. • Genetic counselling may be done but not feasible at present. • Correction of sedentary lifestyle, over-nutrition and obesity for NIDDM. • Avoidance of Alcohol, diabetogenic drugs like oral contraceptives. • Reduction of factors that promote atherosclerosis, e.g., smoking, high blood pressure, elevated cholesterol and high triglyceride levels. • May be directed at target population groups.
  • 30. SECONDARY PREVENTION EARLY DIAGNOSIS – a) Proper screening b) Routine checking of blood sugar, of urine for proteins and ketones, of blood pressure, visual acuity and weight should be done periodically. c) The feet should be examined for any defective blood circulation (Doppler ultrasound probes are advised), loss of sensation and the health of the skin. d) Primary health care – of utmost importance.
  • 31. SECONDARY PREVENTION (cont.) MANAGEMENT – • Proper management of the diabetes is most important to prevent complications. • Investigations used for early diagnosis should be done. • Treatment is based on (a) diet alone - small balanced meals more frequently, (b) diet and oral anti diabetic drugs, or (c) diet and insulin.
  • 32. SECONDARY PREVENTION (cont.) Glycosylated haemoglobin : • estimation at 6 monthly intervals. • long-term index of glucose control. • rationale: glucose in the blood is complexed to a certain fraction of haemoglobin to an extent proportional to the blood glucose concentration.The percentage of such glycosylated haemoglobin reflects the mean blood glucose levels during the red cell life- time (i.e., about the previous 2-3 months)
  • 33. SECONDARY PREVENTION (cont.) Home blood glucose monitoring : • Glucometers - immediate, reasonably accurate, capillary blood glucose measurements • the direct reading Haemoglukotest strips . Self-care : • adherence to diet and drug regimens, • examination of his own urine • blood glucose monitoring • self administration of insulin, • abstinence from alcohol, • maintenance of optimum weight, • attending periodic check-ups, • recognition of symptoms associated with glycosuria and hypoglycaemia, etc.
  • 34. TERTIARY PREVENTION • Diabetes is major cause of disability through its complications, e.g., blindness, kidney failure, coronary thrombosis, gangrene of the lower extremities, etc. • The main objective at the tertiary level is to organize specialized clinics (Diabetic clinics) and units capable of providing diagnostic and management skills of a high order. • The tertiary level should also be involved in basic, clinical and epidemiological research. • local and national registries for diabetics should be established.